Erin K. Brenner - Feb 15, 2023 Form 4 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role
Chief Product Dev. Officer
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Stock symbol
PEARQ
Transactions as of
Feb 15, 2023
Transactions value $
$0
Form type
4
Date filed
2/17/2023, 03:14 PM
Previous filing
Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Restricted Stock Units Award $0 +952K $0.00 952K Feb 15, 2023 Class A Common Stock 952K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock.
F2 The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026.